Archive for MHRA Updates
Batch of metformin oral solution recalled by MHRA due to nitrosamine impurity
Source: MHRA Patients should not stop any treatments without consulting their doctor or pharmacist. A recall notice for one batch (10,452 units) of metformin oral solution has today been...
Medicine Class 2 Recall
There has been a correction to this initial recall, by Aventis Pharma. Please click on this link to see the MHRA source
The Department of Health and Social Care has provided an update on the SSP for Fluoxetine 10mg tablets (SSP05)
Source: NHSBSA-SSP Update 10.08.2021 – The DHSC has provided an update on the Serious Shortage Protocols for Fluoxetine 10mg tablets (SSP05). This SSP has been varied – the revised end...
MHRA recalls contaminated Irbesartan- batches as precautionary measure
Patients should not stop any treatments without consulting their doctor or pharmacist Source: MHRA 9th August 2021 The MHRA today has issued a recall for 25 batches of Irbesartan-containing medicinal...
Field Safety Notices: 2 to 6 August 2021 List of field safety notices (FSNs) from medical device manufacturers from 2 to 6 August
Source: MHRA 9th August 2021 Overview If you receive a field safety notice (FSN) from a manufacturer you must always act on it. MHRA publishes the following for information only....
Class 2 Medicines Recall:Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL (21)A/19
Specific batches of products supplied by the Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. Source: MHRA 9th August 2021 Company...
Central Alert System- Tinzaparin Sodium Alert
Source: MHRA July 29, 2021 Unavailable From Mid October! MHRA has issued an alert via the Central Alert System for Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500...
Contractor Notice: SSP endorsement errors
Source: PSNC/ (NHSBSA) July 28, 2021 Following the announcement of the new Serious Shortage Protocols (SSP) endorsement which was introduced from 1 June 2021, PSNC has been working with NHS Business Services...
Medicine Supply Notification: Nexium® (esomeprazole) 10mg gastro-resistant granules sachets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Nexium® (esomeprazole) 10mg gastro-resistant granules sachetsMSN/2021/038Tier 2 – medium impact Date of issue:...
Medicine Supply Notification: Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solutionMSN/2021/036Tier 2 –...
Medicine Supply Notification: Catapres® (clonidine) 100microgram tablets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Catapres® (clonidine) 100microgram tabletsMSN/2021/037 Tier 2 – medium impact Date of issue: 21/07/2021...
Class 4 Medicines Defect Information, Amoxicillin
Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18 Click here for the source
